SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001297184-20-000027
Filing Date
2020-05-11
Accepted
2020-05-11 16:13:01
Documents
92
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q amph-20200331x10q.htm 10-Q 2534378
2 EX-31.1 amph-20200331ex3111285c4.htm EX-31.1 22849
3 EX-31.2 amph-20200331ex31221ccc3.htm EX-31.2 22975
4 EX-32.1 amph-20200331ex3211b28a8.htm EX-32.1 12327
5 EX-32.2 amph-20200331ex32256e414.htm EX-32.2 12300
  Complete submission text file 0001297184-20-000027.txt   9890335

Data Files

Seq Description Document Type Size
6 EX-101.INS amph-20200331.xml EX-101.INS 2431960
7 EX-101.SCH amph-20200331.xsd EX-101.SCH 62643
8 EX-101.CAL amph-20200331_cal.xml EX-101.CAL 62232
9 EX-101.DEF amph-20200331_def.xml EX-101.DEF 217351
10 EX-101.LAB amph-20200331_lab.xml EX-101.LAB 467861
11 EX-101.PRE amph-20200331_pre.xml EX-101.PRE 423507
Mailing Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730
Business Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730 909-980-9484
Amphastar Pharmaceuticals, Inc. (Filer) CIK: 0001297184 (see all company filings)

IRS No.: 330702205 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36509 | Film No.: 20864905
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences